Phase I study of JR-131 for the treatment of renal anemia
Latest Information Update: 19 Sep 2016
Price :
$35 *
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Anaemia; Kidney disorders
- Focus Adverse reactions
- 19 Sep 2016 New trial record